# To Assess the Effect of HDF Versus High Flux Dialysis on Free Light Chains and Cumulative Albumin Loss, in End Stage Renal Disease Patients.

> **NCT04747067** · NA · COMPLETED · sponsor: **Ain Shams University** · enrollment: 25 (actual)

## Conditions studied

- End Stage Renal Disease
- Hemodiafiltration
- Hemodialysis

## Interventions

- **DEVICE:** BIOPURE 260HF dialyzer

## Key facts

- **NCT ID:** NCT04747067
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-01
- **Primary completion:** 2021-05-01
- **Final completion:** 2021-09-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2022-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04747067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04747067, "To Assess the Effect of HDF Versus High Flux Dialysis on Free Light Chains and Cumulative Albumin Loss, in End Stage Renal Disease Patients.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04747067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*